181 related articles for article (PubMed ID: 23721055)
1. Targeted therapy for non-small cell lung cancer.
Jett JR; Carr LL
Am J Respir Crit Care Med; 2013 Oct; 188(8):907-12. PubMed ID: 23721055
[TBL] [Abstract][Full Text] [Related]
2. Discovery of drug resistance biomarker could improve cancer treatment.
Pharmacogenomics; 2013 Jan; 14(2):125. PubMed ID: 23447824
[No Abstract] [Full Text] [Related]
3. [Personalized treatment in non-small cell lung cancer].
Campos-Parra AD; Cruz-Rico G; Arrieta O
Rev Invest Clin; 2012; 64(4):377-86. PubMed ID: 23227588
[No Abstract] [Full Text] [Related]
4. Crizotinib in the treatment of non-small-cell lung cancer.
Forde PM; Rudin CM
Expert Opin Pharmacother; 2012 Jun; 13(8):1195-201. PubMed ID: 22594847
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy for lung cancer.
Petrosyan F; Daw H; Haddad A; Spiro T
Anticancer Drugs; 2012 Nov; 23(10):1016-21. PubMed ID: 22932130
[TBL] [Abstract][Full Text] [Related]
6. [Current status and perspectives of individualized therapy for non-small cell lung cancer based on molecular targeting].
Shi YK
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):398-400. PubMed ID: 22883466
[No Abstract] [Full Text] [Related]
7. Targeted treatment tested as potential cancer cure.
Hayden EC
Nature; 2011 Nov; 479(7373):281. PubMed ID: 22094668
[No Abstract] [Full Text] [Related]
8. Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
Bunn PA
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5919-20. PubMed ID: 17062660
[No Abstract] [Full Text] [Related]
9. Erlotinib: small-molecule targeted therapy in the treatment of non-small-cell lung cancer.
Smith J
Clin Ther; 2005 Oct; 27(10):1513-34. PubMed ID: 16330289
[TBL] [Abstract][Full Text] [Related]
10. ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development.
Scagliotti G; Stahel RA; Rosell R; Thatcher N; Soria JC
Eur J Cancer; 2012 May; 48(7):961-73. PubMed ID: 22397764
[TBL] [Abstract][Full Text] [Related]
11. Crizotinib: a new treatment option for ALK-positive non-small cell lung cancer.
O'Bryant CL; Wenger SD; Kim M; Thompson LA
Ann Pharmacother; 2013 Feb; 47(2):189-97. PubMed ID: 23386065
[TBL] [Abstract][Full Text] [Related]
12. PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine.
Pilotto S; Peretti U; Novello S; Rossi G; Milella M; Giaj Levra M; Ciuffreda L; Massari F; Brunelli M; Tortora G; Bria E
Expert Opin Pharmacother; 2013 Apr; 14(5):597-608. PubMed ID: 23472711
[TBL] [Abstract][Full Text] [Related]
13. More than just an oncogene translocation and a kinase inhibitor: Kevin's story.
Costa DB
J Clin Oncol; 2012 Jan; 30(1):110-2. PubMed ID: 22067391
[No Abstract] [Full Text] [Related]
14. Second-line treatment for non-small-cell lung cancer: one size does not fit all.
Caponi S; Vasile E; Ginocchi L; Tibaldi C; Borghi F; D'Incecco A; Lucchesi M; Caparello C; Andreuccetti M; Falcone A
Clin Lung Cancer; 2010 Sep; 11(5):320-7. PubMed ID: 20837457
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacology profile of crizotinib (Xalkori(®)Capsules) and clinical findings on this drug].
Nonaka S; Yamaguchi S; Nagasawa T; Tahara M
Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):106-13. PubMed ID: 23391552
[No Abstract] [Full Text] [Related]
16. [Erlotinib. A new option for non-small cell lung cancer].
Polk B
Med Monatsschr Pharm; 2006 Jan; 29(1):4-6. PubMed ID: 16463547
[No Abstract] [Full Text] [Related]
17. Targeting the epidermal growth factor receptor in non-small cell lung cancer.
Herbst RS; Bunn PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5813-24. PubMed ID: 14676101
[TBL] [Abstract][Full Text] [Related]
18. Paired drugs give advanced lung cancer a double punch.
Health News; 2006 Sep; 12(9):15. PubMed ID: 17144020
[No Abstract] [Full Text] [Related]
19. Modern treatment of lung cancer: case 2. Response to erlotinib after failure of gefitinib in a patient with advanced non-small-cell lung carcinoma.
Garfield DH
J Clin Oncol; 2005 Oct; 23(30):7738-40. PubMed ID: 16234533
[No Abstract] [Full Text] [Related]
20. Inhibitors of the anaplastic lymphoma kinase.
Mologni L
Expert Opin Investig Drugs; 2012 Jul; 21(7):985-94. PubMed ID: 22612599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
